Literature DB >> 27488505

Variants and pitfalls on radioiodine scans in pediatric patients with differentiated thyroid carcinoma.

Mohamed Mostafa1, Reza Vali2, Jeffrey Chan2, Yusuaf Omarkhail2, Amer Shammas2.   

Abstract

BACKGROUND: Potentially false-positive findings on radioiodine scans in children with differentiated thyroid carcinoma can mimic functioning thyroid tissue and functioning thyroid carcinomatous tissue. Such false-positive findings comprise variants and pitfalls that can vary slightly in children as compared with adults.
OBJECTIVE: To determine the patterns and frequency of these potential false-positive findings on radioiodine scans in children with differentiated thyroid carcinoma.
MATERIALS AND METHODS: We reviewed a total of 223 radioiodine scans from 53 pediatric patients (mean age 13.3 years, 37 girls) with differentiated thyroid carcinoma. Focal or regional activity that likely did not represent functioning thyroid tissue or functioning thyroid carcinomatous tissue were categorized as variants or pitfalls. The final diagnosis was confirmed by reviewing the concurrent and follow-up clinical data, correlative ultrasonography, CT scanning, serum thyroglobulin and antithyroglobulin antibody levels. We calculated the frequency of these variants and pitfalls from diagnostic and post-therapy radioiodine scans.
RESULTS: The most common variant on the radioiodine scans was the thymic activity (24/223, 10.8%) followed by the cardiac activity (8/223, 3.6%). Salivary contamination and star artifact, caused by prominent thyroid remnant, were the most important observed pitfalls.
CONCLUSION: Variants and pitfalls that mimic functioning thyroid tissue or functioning thyroid carcinomatous tissue on radioiodine scan in children with differentiated thyroid carcinoma are not infrequent, but they decrease in frequency on successive radioiodine scans. Potential false-positive findings can be minimized with proper knowledge of the common variants and pitfalls in children and correlation with clinical, laboratory and imaging data.

Entities:  

Keywords:  Children; Differentiated thyroid cancer; Pitfalls; Thyroid; Variants; Whole-body radioiodine scan

Mesh:

Substances:

Year:  2016        PMID: 27488505     DOI: 10.1007/s00247-016-3655-2

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  28 in total

Review 1.  Thymic uptake of radiopharmaceuticals.

Authors:  Leonard P Connolly; Susan A Connolly
Journal:  Clin Nucl Med       Date:  2003-08       Impact factor: 7.794

2.  Estimated risks of radiation-induced fatal cancer from pediatric CT.

Authors:  D Brenner; C Elliston; E Hall; W Berdon
Journal:  AJR Am J Roentgenol       Date:  2001-02       Impact factor: 3.959

Review 3.  False-positive iodine-131 whole-body scan findings in patients with differentiated thyroid carcinoma: report of 11 cases and review of the literature.

Authors:  Leckzinscka Buton; Olivier Morel; Patricia Gault; Frédéric Illouz; Patrice Rodien; Vincent Rohmer
Journal:  Ann Endocrinol (Paris)       Date:  2013-06-21       Impact factor: 2.478

4.  Bronchiectasis simulating pulmonary metastases on iodine-131 scintigraphy in well-differentiated thyroid carcinoma.

Authors:  Ian Jong; Kim Taubman; Stephen Schlicht
Journal:  Clin Nucl Med       Date:  2005-10       Impact factor: 7.794

5.  Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy.

Authors:  Hasan Raza; Aakif U Khan; Abid Hameed; Ayub Khan
Journal:  Nucl Med Commun       Date:  2006-06       Impact factor: 1.690

6.  Iodine concentration by the thymus in thyroid carcinoma.

Authors:  F Vermiglio; E Baudin; J P Travagli; B Caillou; P Fragu; M Ricard; M Schlumberger
Journal:  J Nucl Med       Date:  1996-11       Impact factor: 10.057

7.  Radioiodine concentration by the thymus in differentiated thyroid carcinoma: report of five cases.

Authors:  Maria Eduarda Mello; Rodrigo C Flamini; Rossana Corbo; Marcelo Mamede
Journal:  Arq Bras Endocrinol Metabol       Date:  2009-10

8.  Clinical implications of diffuse hepatic uptake observed in postablative and post-therapeutic I-131 scans.

Authors:  Ozgür Omür; Ayşegül Akgün; Zehra Ozcan; Ciğdem Sen; Hayal OzkiIiç
Journal:  Clin Nucl Med       Date:  2009-01       Impact factor: 7.794

9.  Unusual patterns of I-131 contamination.

Authors:  Mehmet Ozguven; Seyfettin Ilgan; Nuri Arslan; A Ozgur Karacalioglu; Dogangun Yuksel; Sabri Dundar
Journal:  Ann Nucl Med       Date:  2004-05       Impact factor: 2.668

10.  Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer.

Authors:  T Michigishi; Y Mizukami; N Shuke; K Yokoyama; M Noguchi; Y Watanabe; O Matsui; T Aburano; N Tonami; K Hisada
Journal:  Eur J Nucl Med       Date:  1993-01
View more
  3 in total

Review 1.  Initial treatment of pediatric differentiated thyroid cancer: a review of the current risk-adaptive approach.

Authors:  Marguerite T Parisi; Hedieh Khalatbari; Sanjay R Parikh; Adina Alazraki
Journal:  Pediatr Radiol       Date:  2019-10-16

2.  The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer.

Authors:  Hee Kyung Kim; Jee Hee Yoon; Jin Seong Cho; Seong Young Kwon; Su Woong Yoo; Ho-Cheol Kang
Journal:  Korean J Intern Med       Date:  2019-07-29       Impact factor: 2.884

3.  Paediatric differentiated thyroid carcinoma: a UK National Clinical Practice Consensus Guideline.

Authors:  Sasha R Howard; Sarah Freeston; Barney Harrison; Louise Izatt; Sonali Natu; Kate Newbold; Sabine Pomplun; Helen A Spoudeas; Sophie Wilne; Tom R Kurzawinski; Mark N Gaze
Journal:  Endocr Relat Cancer       Date:  2022-09-07       Impact factor: 5.900

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.